...
首页> 外文期刊>Thoracic cancer. >Handling benign interlobar lymphadenopathy during thoracoscopic lobectomy
【24h】

Handling benign interlobar lymphadenopathy during thoracoscopic lobectomy

机译:在胸腔镜肺切除术期间处理良性间白条淋巴结病

获取原文
           

摘要

The presence of calcified or inflammatory lymph nodes between the target bronchus and pulmonary artery is a huge challenge when performing thoracoscopic lobectomy as it may frequently result in tearing of the vessel, and massive bleeding. Herein, we describe a simple strategy in which thoracoscopic lobectomy was safely completed in similar cases. After fissure dissection, the target pulmonary artery was exposed by more than two-thirds of its circumference. A needle was passed across the nodes and the target vessel was closed with a proximal and distal suture. After dissection of lymphadenopathies, the target bronchus was exposed, and stapled. This strategy was applied with success to complete right lower lobectomies for cancer in three patients. No complications occurred during the operation. Only one patient had persistent air leaks that spontaneously ceased 11?days later. Final pathology showed pN0 disease in all cases.
机译:靶支气管和肺动脉之间的钙化或炎症性淋巴结的存在是在进行胸腔镜型肺切除术时的巨大挑战,因为它可能经常导致血管撕裂和大量出血。 在此,我们描述了一种简单的策略,其中在类似的情况下安全地完成了胸腔镜肺术。 在裂隙剖检后,靶肺动脉暴露超过其周长的三分之二。 通过节点通过针头,并且用近端和远端缝合物关闭靶容器。 在解剖淋巴结病后,靶支气管暴露并钉在一起。 在三名患者中占据了成功以完成癌症的右下叶片术语。 操作期间没有发生任何并发症。 只有一名患者持续存在漏洞,自发地停止11天。 在所有情况下,最终病理学显示PN0病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号